Labcorp Holdings LH Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 114.2%+2.5pp | 113.2%+1.7pp | 112.3%+1.0pp | 111.8%+0.7pp | 111.7%+0.1pp | |
| Operating margin | 38.6%— | 36.7%— | 35.2%— | —— | —— | |
| Net margin | 24.8%— | 23.7%— | 23.2%— | —— | —— | |
| Returns | ||||||
| Return on equity | 41%— | 38.9%— | 37.8%— | —— | —— | |
| Return on invested capital | 38.7%— | 37.2%— | 35.8%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 3.1×+0.1× | 3.1×+0.2× | 3×+0.3× | 3×+0.3× | 3×+0.3× | |
| Liquidity | ||||||
| Current ratio | 6.2×+0.6× | 6.3×+1.7× | 6.3×+2.0× | 6.2×+1.9× | 5.6×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 3×0.0× | 2.9×+0.3× | 3.1×+0.7× | 3.2×+0.9× | 3×+0.5× | |
| Net debt / EBITDA | 11.4×— | 12×— | 12.4×— | —— | —— | |
| Valuation | ||||||
| Market capitalization | $88.61B+18.8% | $86.11B+17.2% | $84.49B+14.8% | $79.43B+10.0% | $74.57B+2.1% | |
| Price / earnings | 103.8×— | 107.1×— | 109×— | —— | —— | |
| Price / sales | 6.4×+0.6× | 6.3×+0.5× | 6.3×+0.4× | 6.1×+0.2× | 5.8×-0.2× | |
| Price / book | 10.3×+1.1× | 10.1×+1.0× | 10.1×+0.9× | 9.6×+0.5× | 9.2×+0.2× | |
| EV / EBITDA | 55.5×— | 56.9×— | 58.3×— | —— | —— | |
| Dividend yield | 4.4%-0.9pp | 4.5%-0.9pp | 4.6%-0.8pp | 4.9%-0.7pp | 5.3%-0.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Labcorp Holdings's profit margins?
- Labcorp Holdings (LH) runs a 28.8% gross margin and a 10.2% operating margin, with a 6.7% net margin.
- Where do Labcorp Holdings's ratios come from?
- Every ratio is computed from Labcorp Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
